CollPlant Biotechnologies Ltd. (CLGN)
0.3203
-0.02
(-6.70%)
USD |
NASDAQ |
Sep 03, 16:00
0.33
+0.01
(+3.03%)
After-Hours: 20:00
CollPlant Biotechnologies Shareholders Equity (Quarterly) : 4.886M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 4.886M |
| December 31, 2025 | 6.081M |
| September 30, 2025 | 9.305M |
| June 30, 2025 | 12.50M |
| March 31, 2025 | 12.40M |
| December 31, 2024 | 13.46M |
| September 30, 2024 | 16.92M |
| June 30, 2024 | 20.73M |
| March 31, 2024 | 24.45M |
| December 31, 2023 | 28.34M |
| September 30, 2023 | 32.40M |
| June 30, 2023 | 36.04M |
| March 31, 2023 | 29.89M |
| December 31, 2022 | 32.28M |
| September 30, 2022 | 35.81M |
| June 30, 2022 | 39.50M |
| March 31, 2022 | 43.20M |
| December 31, 2021 | 45.12M |
| September 30, 2021 | 48.48M |
| June 30, 2021 | 49.44M |
| March 31, 2021 | 50.65M |
| December 31, 2020 | 4.477M |
| September 30, 2020 | 6.875M |
| June 30, 2020 | 5.777M |
| March 31, 2020 |
| Date | Value |
|---|---|
| December 31, 2019 | |
| September 30, 2019 | -1.372M |
| June 30, 2019 | 1.828M |
| March 31, 2019 | 3.102M |
| December 31, 2018 | 4.797M |
| September 30, 2018 | 3.698M |
| June 30, 2018 | 3.534M |
| March 31, 2018 | 4.984M |
| December 31, 2017 | 2.616M |
| September 30, 2017 | 0.5962M |
| June 30, 2017 | 1.600M |
| March 31, 2017 | 2.022M |
| December 31, 2016 | 1.341M |
| September 30, 2016 | 3.073M |
| June 30, 2016 | 4.254M |
| March 31, 2016 | 2.904M |
| December 31, 2015 | 2.513M |
| September 30, 2015 | 3.859M |
| June 30, 2015 | 2.172M |
| March 31, 2015 | 2.748M |
| December 31, 2014 | 3.678M |
| September 30, 2014 | 4.814M |
| June 30, 2014 | 5.943M |
| March 31, 2014 | 6.686M |
| December 31, 2013 | 7.803M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Anika Therapeutics, Inc. | 137.28M |
| Perspective Therapeutics, Inc. | 323.86M |
| MiMedx Group, Inc. | 216.00M |
| Regentis Biomaterials Ltd. | -- |
| Xylo Technologies Ltd. | -- |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 9.183M |
| Total Liabilities (Quarterly) | 4.297M |
| Debt to Equity Ratio | 0.5422 |
| Current Ratio | 2.268 |
| Net Debt Paydown Yield | 1.12% |